213 related articles for article (PubMed ID: 32696397)
1. TAR DNA-Binding Protein 43 is Cleaved by the Protease 3C of Enterovirus A71.
Wo X; Yuan Y; Xu Y; Chen Y; Wang Y; Zhao S; Lin L; Zhong X; Wang Y; Zhong Z; Zhao W
Virol Sin; 2021 Feb; 36(1):95-103. PubMed ID: 32696397
[TBL] [Abstract][Full Text] [Related]
2. Enterovirus D68 Infection Induces TDP-43 Cleavage, Aggregation, and Neurotoxicity.
Zhang L; Yang J; Li H; Zhang Z; Ji Z; Zhao L; Wei W
J Virol; 2023 Apr; 97(4):e0042523. PubMed ID: 37039659
[TBL] [Abstract][Full Text] [Related]
3. dsRNA Binding Domain of PKR Is Proteolytically Released by Enterovirus A71 to Facilitate Viral Replication.
Chang YH; Lau KS; Kuo RL; Horng JT
Front Cell Infect Microbiol; 2017; 7():284. PubMed ID: 28702377
[TBL] [Abstract][Full Text] [Related]
4. The 3C protease of enterovirus A71 counteracts the activity of host zinc-finger antiviral protein (ZAP).
Xie L; Lu B; Zheng Z; Miao Y; Liu Y; Zhang Y; Zheng C; Ke X; Hu Q; Wang H
J Gen Virol; 2018 Jan; 99(1):73-85. PubMed ID: 29182509
[TBL] [Abstract][Full Text] [Related]
5. Hsp27 Responds to and Facilitates Enterovirus A71 Replication by Enhancing Viral Internal Ribosome Entry Site-Mediated Translation.
Dan X; Wan Q; Yi L; Lu J; Jiao Y; Li H; Song D; Chen Y; Xu H; He ML
J Virol; 2019 May; 93(9):. PubMed ID: 30814282
[TBL] [Abstract][Full Text] [Related]
6. Interplays between Enterovirus A71 and the innate immune system.
Chen KR; Ling P
J Biomed Sci; 2019 Dec; 26(1):95. PubMed ID: 31787104
[TBL] [Abstract][Full Text] [Related]
7. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
J Virol; 2019 May; 93(10):. PubMed ID: 30867299
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
[No Abstract] [Full Text] [Related]
9. Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection.
Xing J; Wang K; Wang G; Li N; Zhang Y
Arch Virol; 2022 Dec; 167(12):2483-2501. PubMed ID: 36171507
[TBL] [Abstract][Full Text] [Related]
10. RSAD2 and AIM2 Modulate Coxsackievirus A16 and Enterovirus A71 Replication in Neuronal Cells in Different Ways That May Be Associated with Their 5' Nontranslated Regions.
Yogarajah T; Ong KC; Perera D; Wong KT
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263272
[TBL] [Abstract][Full Text] [Related]
11. Global quantitative proteomic analysis profiles of host protein expression in response to enterovirus A71 infection in bronchial epithelial cells based on tandem mass tag (TMT) peptide labeling coupled with LC-MS/MS uncovers the key role of proteasome in virus replication.
Yajie H; Shenglan W; Wei Z; Rufang L; Tingting Y; Yunhui Z; Jie S
Virus Res; 2023 Jun; 330():199118. PubMed ID: 37072100
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease.
Wang CY; Huang AC; Hour MJ; Huang SH; Kung SH; Chen CH; Chen IC; Chang YS; Lien JC; Lin CW
Viruses; 2015 Jun; 7(6):3155-71. PubMed ID: 26090728
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of inhibitors against 3C protease of coxsackievirus A16 and enterovirus A71 causing hand, foot and mouth disease: A molecular dynamics study.
Jetsadawisut W; Nutho B; Meeprasert A; Rungrotmongkol T; Kungwan N; Wolschann P; Hannongbua S
Biophys Chem; 2016 Dec; 219():9-16. PubMed ID: 27668727
[TBL] [Abstract][Full Text] [Related]
14. Proteomic and phosphoproteomic analysis of responses to enterovirus A71 infection reveals novel targets for antiviral and viral replication.
Lin D; Dong X; Xiao X; Xiang Z; Lei X; Wang J
Antiviral Res; 2023 Dec; 220():105761. PubMed ID: 37992763
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of SP81 peptide against Enterovirus A71 (EV-A71).
Abd-Aziz N; Lee MF; Ong SK; Poh CL
Virology; 2024 Jan; 589():109941. PubMed ID: 37984152
[TBL] [Abstract][Full Text] [Related]
16. Advances in anti-EV-A71 drug development research.
Wang S; Pang Z; Fan H; Tong Y
J Adv Res; 2024 Feb; 56():137-156. PubMed ID: 37001813
[TBL] [Abstract][Full Text] [Related]
17. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
18. Viral determinants that drive Enterovirus-A71 fitness and virulence.
Ang PY; Chong CWH; Alonso S
Emerg Microbes Infect; 2021 Dec; 10(1):713-724. PubMed ID: 33745413
[TBL] [Abstract][Full Text] [Related]
19. [Progress in Research on Structure, Function and Antiviral of Enterovirus A71 3C Protein].
Li J; Wen H; Wang Z
Bing Du Xue Bao; 2015 Jul; 31(4):468-73. PubMed ID: 26524922
[TBL] [Abstract][Full Text] [Related]
20. Cordycepin Inhibits Enterovirus A71 Replication and Protects Host Cell from Virus-Induced Cytotoxicity through Adenosine Action Pathway.
Lee YP; Yu CK; Wong TW; Chen LC; Huang BM
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
